Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - September 3, 2008
Anthony Bugembe
The drugs, which included those for malaria, were from India.
They were delivered at the National Medical Stores on Tuesday.
Martin Oteba, the acting assistant commissioner in charge of pharmaceuticals, declined to disclose the quantities and types of drugs delivered.
"I am still waiting for an update from the National Medical Stores," he told The New Vision yesterday.
Last month, the Government ordered for ARVs worth $1.8m (sh3b) from Quality Chemicals, a pharmaceutical company based in Luzira, Kampala.
The firm entered into a joint venture with CIPLA, a leading Indian pharmaceutical firm, to produce the drugs and sell them at a subsidised price. An estimated 1.1 million Ugandans are living with the HIV virus that causes AIDS.
The number of people in immediate need of the drugs had risen from about 225,000 in 2006 to 312,000 today.
Currently, 130,000 patients, including 10,000 children, are receiving ARVs.
On average, 1,500 patients are enrolled on treatment every month.
Sources at some ARVs designated sites in the country told The New Vision that the amount of drugs given to people living with AIDS had been cut down drastically due to the shortage of ARVs.
"Some of the patients, who were receiving drugs for two months, now get ARVs for only two weeks," the source said.
Highly active antiretroviral therapy, the medication that suppresses HIV to the extent that it can not be detected in blood, first became available in Uganda in 1998.
080903
NV080905
Copyright © 2008 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .